Page last updated: 2024-11-05

2,4-thiazolidinedione and Hyperplasia

2,4-thiazolidinedione has been researched along with Hyperplasia in 2 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research Excerpts

ExcerptRelevanceReference
"Insulin resistance is defined as a state of subnormal biological response to normal quantity of insulin."2.43[Insulin resistance: the adipose tissue in the focus]. ( Urich, E, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takagi, T1
Yamamuro, A1
Tamita, K1
Katayama, M1
Morioka, S1
Urich, E1

Reviews

1 review available for 2,4-thiazolidinedione and Hyperplasia

ArticleYear
[Insulin resistance: the adipose tissue in the focus].
    Orvosi hetilap, 2005, Oct-23, Volume: 146, Issue:43

    Topics: Adipocytes; Adipose Tissue; Diabetes Mellitus, Type 2; Humans; Hyperplasia; Hypertrophy; Hypoglycemi

2005

Other Studies

1 other study available for 2,4-thiazolidinedione and Hyperplasia

ArticleYear
Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
    Journal of cardiology, 2005, Volume: 45, Issue:4

    Topics: Aged; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Femal

2005